Lien Dejager

Company: argenx

Job title: Biomarker Lead

Seminars:

Addressing the Diagnostic Gap: The Need for Customised IVD Solutions for Rare Diseases 12:20 pm

Navigating the IVD landscape for rare diseases: Exploring strategies for addressing the challenges faced when IVDs are unavailable Market considerations: Discussing the implications of CE marking termination on IVD development. Assay validation considerations: Examining the complexities of cross-validation of assays across regions and the difference between validating biomarker assays used for exploratory vs diagnostic purposesRead more

day: Day 2 - Track A (1)